HEADER APOPTOSIS INHIBITOR 30-NOV-11 3UW4 TITLE CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO GDC0152 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2, BACULOVIRAL COMPND 3 IAP REPEAT-CONTAINING PROTEIN 4; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: BIR3 RESIDUES 266-354; COMPND 6 SYNONYM: C-IAP1, IAP HOMOLOG B, INHIBITOR OF APOPTOSIS PROTEIN 2, COMPND 7 IAP-2, HIAP-2, HIAP2, RING FINGER PROTEIN 48, TNFR2-TRAF-SIGNALING COMPND 8 COMPLEX PROTEIN 2, E3 UBIQUITIN-PROTEIN LIGASE XIAP, IAP-LIKE COMPND 9 PROTEIN, ILP, HILP, INHIBITOR OF APOPTOSIS PROTEIN 3, IAP-3, HIAP-3, COMPND 10 HIAP3, X-LINKED INHIBITOR OF APOPTOSIS PROTEIN, X-LINKED IAP; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES; COMPND 13 MOL_ID: 2; COMPND 14 MOLECULE: GDC0152; COMPND 15 CHAIN: Z; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: API1, BIRC2, CIAP1, IAP2, MIHB, RNF48, API3, BIRC4, IAP3, SOURCE 6 XIAP; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 OTHER_DETAILS: SYNTHETIC INHIBITOR KEYWDS APOPTOSIS INHIBITOR, BIR DOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR B.MAURER,S.HYMOWITZ REVDAT 6 06-DEC-23 3UW4 1 REMARK REVDAT 5 13-SEP-23 3UW4 1 SEQADV LINK REVDAT 4 02-AUG-17 3UW4 1 SOURCE REMARK REVDAT 3 23-MAY-12 3UW4 1 JRNL REVDAT 2 28-MAR-12 3UW4 1 JRNL REVDAT 1 22-FEB-12 3UW4 0 JRNL AUTH J.A.FLYGARE,M.BERESINI,N.BUDHA,H.CHAN,I.T.CHAN,S.CHEETI, JRNL AUTH 2 F.COHEN,K.DESHAYES,K.DOERNER,S.G.ECKHARDT,L.O.ELLIOTT, JRNL AUTH 3 B.FENG,M.C.FRANKLIN,S.F.REISNER,L.GAZZARD,J.HALLADAY, JRNL AUTH 4 S.G.HYMOWITZ,H.LA,P.LORUSSO,B.MAURER,L.MURRAY,E.PLISE, JRNL AUTH 5 C.QUAN,J.P.STEPHAN,S.G.YOUNG,J.TOM,V.TSUI,J.UM, JRNL AUTH 6 E.VARFOLOMEEV,D.VUCIC,A.J.WAGNER,H.J.WALLWEBER,L.WANG, JRNL AUTH 7 J.WARE,Z.WEN,H.WONG,J.M.WONG,M.WONG,S.WONG,R.YU,K.ZOBEL, JRNL AUTH 8 W.J.FAIRBROTHER JRNL TITL DISCOVERY OF A POTENT SMALL-MOLECULE ANTAGONIST OF INHIBITOR JRNL TITL 2 OF APOPTOSIS (IAP) PROTEINS AND CLINICAL CANDIDATE FOR THE JRNL TITL 3 TREATMENT OF CANCER (GDC-0152). JRNL REF J.MED.CHEM. V. 55 4101 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22413863 JRNL DOI 10.1021/JM300060K REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 7503 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 736 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 25 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.83 REMARK 3 REFLECTION IN BIN (WORKING SET) : 325 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.2090 REMARK 3 BIN FREE R VALUE SET COUNT : 40 REMARK 3 BIN FREE R VALUE : 0.2960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 746 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 53 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.63000 REMARK 3 B22 (A**2) : -0.98000 REMARK 3 B33 (A**2) : 2.61000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.142 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.091 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.830 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 780 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 3 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1053 ; 1.370 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9 ; 1.023 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 86 ; 5.150 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 39 ;31.199 ;23.077 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 112 ;13.072 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ;14.882 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 99 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 618 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 252 A 402 REMARK 3 ORIGIN FOR THE GROUP (A): -6.7745 2.3651 -3.9479 REMARK 3 T TENSOR REMARK 3 T11: 0.0282 T22: 0.0134 REMARK 3 T33: 0.0090 T12: -0.0062 REMARK 3 T13: 0.0095 T23: -0.0051 REMARK 3 L TENSOR REMARK 3 L11: 2.2985 L22: 1.4960 REMARK 3 L33: 1.2721 L12: -0.8087 REMARK 3 L13: 0.6958 L23: -0.6166 REMARK 3 S TENSOR REMARK 3 S11: 0.0037 S12: 0.0546 S13: 0.0889 REMARK 3 S21: 0.0238 S22: -0.0242 S23: -0.0263 REMARK 3 S31: -0.0054 S32: 0.0322 S33: 0.0205 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 3UW4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-DEC-11. REMARK 100 THE DEPOSITION ID IS D_1000069282. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.6 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7548 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08500 REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.46700 REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB CODE 2UVL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 32.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION (4MG/ML CIAP WITH 1 REMARK 280 MM GDC-0152, 50 MM HEPES PH 7.2, 300 MM NACL, 0.2 MM TCEP) WAS REMARK 280 MIXED WITH EQUAL VOLUMES OF RESEVOIR SOLUTION (0.1 M TRIS-HCL PH REMARK 280 8.6, 0.5 M MAGNESIUM FORMATE)., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.84550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 28.79900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.69000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 28.79900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.84550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 18.69000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, Z REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE GDC0152 IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: GDC0152 REMARK 400 CHAIN: Z REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 249 REMARK 465 SER A 250 REMARK 465 HIS A 251 REMARK 465 SER A 339 REMARK 465 LEU A 340 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 287 -131.89 46.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 402 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 6 O REMARK 620 2 HIS A 335 ND1 98.0 REMARK 620 3 HIS A 338 NE2 112.4 102.2 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 292 SG REMARK 620 2 CYS A 295 SG 107.4 REMARK 620 3 HIS A 312 NE2 105.1 115.3 REMARK 620 4 CYS A 319 SG 113.2 109.0 106.9 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN Z OF GDC0152 DBREF 3UW4 A 252 329 UNP Q13490 BIRC2_HUMAN 266 343 DBREF 3UW4 A 330 340 UNP P98170 XIAP_HUMAN 338 348 DBREF 3UW4 Z 1 4 PDB 3UW4 3UW4 1 4 SEQADV 3UW4 GLY A 249 UNP Q13490 EXPRESSION TAG SEQADV 3UW4 SER A 250 UNP Q13490 EXPRESSION TAG SEQADV 3UW4 HIS A 251 UNP Q13490 EXPRESSION TAG SEQADV 3UW4 ALA A 278 UNP Q13490 SER 292 ENGINEERED MUTATION SEQADV 3UW4 SER A 294 UNP Q13490 CYS 308 ENGINEERED MUTATION SEQADV 3UW4 GLY A 318 UNP Q13490 ARG 332 ENGINEERED MUTATION SEQRES 1 A 92 GLY SER HIS MET GLN THR HIS ALA ALA ARG MET ARG THR SEQRES 2 A 92 PHE MET TYR TRP PRO SER SER VAL PRO VAL GLN PRO GLU SEQRES 3 A 92 GLN LEU ALA ALA ALA GLY PHE TYR TYR VAL GLY ARG ASN SEQRES 4 A 92 ASP ASP VAL LYS CYS PHE SER CYS ASP GLY GLY LEU ARG SEQRES 5 A 92 CYS TRP GLU SER GLY ASP ASP PRO TRP VAL GLU HIS ALA SEQRES 6 A 92 LYS TRP PHE PRO GLY CYS GLU PHE LEU ILE ARG MET LYS SEQRES 7 A 92 GLY GLN GLU TYR ILE ASN ASN ILE HIS LEU THR HIS SER SEQRES 8 A 92 LEU SEQRES 1 Z 4 MAA CHG PRO 0DQ MODRES 3UW4 MAA Z 1 ALA N-METHYL-L-ALANINE HET MAA Z 1 6 HET CHG Z 2 10 HET 0DQ Z 4 12 HET ZN A 401 1 HET ZN A 402 1 HETNAM MAA N-METHYL-L-ALANINE HETNAM CHG CYCLOHEXYL-GLYCINE HETNAM 0DQ 4-PHENYL-1,2,3-THIADIAZOL-5-AMINE HETNAM ZN ZINC ION FORMUL 2 MAA C4 H9 N O2 FORMUL 2 CHG C8 H15 N O2 FORMUL 2 0DQ C8 H7 N3 S FORMUL 3 ZN 2(ZN 2+) FORMUL 5 HOH *53(H2 O) HELIX 1 1 THR A 254 THR A 261 1 8 HELIX 2 2 GLN A 272 ALA A 279 1 8 HELIX 3 3 ASP A 307 PHE A 316 1 10 HELIX 4 4 CYS A 319 GLY A 327 1 9 HELIX 5 5 GLY A 327 HIS A 338 1 12 SHEET 1 A 3 PHE A 281 TYR A 283 0 SHEET 2 A 3 VAL A 290 CYS A 292 -1 O LYS A 291 N TYR A 282 SHEET 3 A 3 GLY A 298 LEU A 299 -1 O LEU A 299 N VAL A 290 LINK C MAA Z 1 N CHG Z 2 1555 1555 1.34 LINK C CHG Z 2 N PRO Z 3 1555 1555 1.34 LINK C PRO Z 3 N25 0DQ Z 4 1555 1555 1.35 LINK O HOH A 6 ZN ZN A 402 1555 1555 2.03 LINK SG CYS A 292 ZN ZN A 401 1555 1555 2.31 LINK SG CYS A 295 ZN ZN A 401 1555 1555 2.34 LINK NE2 HIS A 312 ZN ZN A 401 1555 1555 2.07 LINK SG CYS A 319 ZN ZN A 401 1555 1555 2.34 LINK ND1 HIS A 335 ZN ZN A 402 1555 1555 2.07 LINK NE2 HIS A 338 ZN ZN A 402 1555 1555 2.06 SITE 1 AC1 4 CYS A 292 CYS A 295 HIS A 312 CYS A 319 SITE 1 AC2 4 HOH A 6 CYS A 301 HIS A 335 HIS A 338 SITE 1 AC3 13 HOH A 8 VAL A 290 GLY A 298 LEU A 299 SITE 2 AC3 13 ARG A 300 CYS A 301 GLU A 303 ASP A 306 SITE 3 AC3 13 GLU A 311 TRP A 315 PRO A 317 ASN A 332 SITE 4 AC3 13 HIS A 335 CRYST1 35.691 37.380 57.598 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028018 0.000000 0.000000 0.00000 SCALE2 0.000000 0.026752 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017362 0.00000